Login
Home
Charts
Search
Watchlist
Products

Parmax Pharma Ltd

PARMAX·BSE
₹136.400.00%Mon, 21 Sept '26
Industry:Pharmaceuticals Bulk Drugs
Indices:

Parmax Pharma Ltd

PARMAX
BSE
₹136.40
0.00%
|Mon, 21 Sept '26
SOICxStockScans Reports
Industry
Pharmaceuticals Bulk Drugs
Indices
View
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹94Cr
Close
Close Price
₹136.40
Industry
Industry
Pharmaceuticals Bulk Drugs
PE
Price To Earnings
—
PS
Price To Sales
5.10
Revenue
Revenue
₹18Cr
Rev Gr TTM
Revenue Growth TTM
-17.64%
PAT Gr TTM
PAT Growth TTM
58.39%

Quarterly Results

Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
414896523438
Growth YoY
Revenue Growth YoY%
91.1-75.1-33.2458.6128.0372.213.4-75.2-72.7-31.1-31.5323.7
Expenses
ExpensesCr
525796524557
Operating Profit
Operating ProfitCr
-1-1-1100-10-20-21
OPM
OPM%
-18.7-86.5-18.56.72.21.6-11.6-12.9-62.9-4.4-46.810.1
Other Income
Other IncomeCr
000000-100002
Interest Expense
Interest ExpenseCr
000000000010
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
-1-2-1000-2-1-2-1-22
Tax
TaxCr
0000000000-20
PAT
PATCr
-1-2-1000-1-1-2-1-12
Growth YoY
PAT Growth YoY%
-95.7-200.6-952.9100.883.977.7-2.8-7,700.0-845.5-87.261.1389.5
NPM
NPM%
-33.7-131.6-34.00.1-2.4-6.2-30.9-39.2-82.2-16.9-17.526.8
EPS
EPS₹
-3.7-4.7-3.90.0-0.6-1.1-4.0-2.0-5.6-2.0-1.65.9
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
414896523438
Growth YoY
Revenue Growth YoY%
91.1-75.1-33.2458.6128.0372.213.4-75.2-72.7-31.1-31.5323.7
Expenses
ExpensesCr
525796524557
Operating Profit
Operating ProfitCr
-1-1-1100-10-20-21
OPM
OPM%
-18.7-86.5-18.56.72.21.6-11.6-12.9-62.9-4.4-46.810.1
Other Income
Other IncomeCr
000000-100002
Interest Expense
Interest ExpenseCr
000000000010
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
-1-2-1000-2-1-2-1-22
Tax
TaxCr
0000000000-20
PAT
PATCr
-1-2-1000-1-1-2-1-12
Growth YoY
PAT Growth YoY%
-95.7-200.6-952.9100.883.977.7-2.8-7,700.0-845.5-87.261.1389.5
NPM
NPM%
-33.7-131.6-34.00.1-2.4-6.2-30.9-39.2-82.2-16.9-17.526.8
EPS
EPS₹
-3.7-4.7-3.90.0-0.6-1.1-4.0-2.0-5.6-2.0-1.65.9

Profit & Loss

Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
0012122126181511281218
Growth
Revenue Growth%
0.874.425.3-30.4-15.5-28.3155.2-57.1-17.6
Expenses
ExpensesCr
0011111923161314281621
Operating Profit
Operating ProfitCr
00112332-30-4-3
OPM
OPM%
9.19.38.413.014.014.6-30.50.9-30.1-13.6
Other Income
Other IncomeCr
000000000-102
Interest Expense
Interest ExpenseCr
000000001111
Depreciation
DepreciationCr
001112222111
PBT
PBTCr
00001100-6-2-6-3
Tax
TaxCr
0000000000-2-2
PAT
PATCr
00000100-6-2-4-1
Growth
PAT Growth%
-108.0106.914,404.2444.776.0-81.2-173.5-5,425.763.6-98.658.4
NPM
NPM%
0.00.72.02.90.8-0.7-52.0-7.4-34.3-6.5
EPS
EPS₹
0.00.00.00.21.12.00.4-0.3-15.4-5.6-11.1-3.2
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
0012122126181511281218
Growth
Revenue Growth%
0.874.425.3-30.4-15.5-28.3155.2-57.1-17.6
Expenses
ExpensesCr
0011111923161314281621
Operating Profit
Operating ProfitCr
00112332-30-4-3
OPM
OPM%
9.19.38.413.014.014.6-30.50.9-30.1-13.6
Other Income
Other IncomeCr
000000000-102
Interest Expense
Interest ExpenseCr
000000001111
Depreciation
DepreciationCr
001112222111
PBT
PBTCr
00001100-6-2-6-3
Tax
TaxCr
0000000000-2-2
PAT
PATCr
00000100-6-2-4-1
Growth
PAT Growth%
-108.0106.914,404.2444.776.0-81.2-173.5-5,425.763.6-98.658.4
NPM
NPM%
0.00.72.02.90.8-0.7-52.0-7.4-34.3-6.5
EPS
EPS₹
0.00.00.00.21.12.00.4-0.3-15.4-5.6-11.1-3.2

Balance Sheet

Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
44444444444
Reserves
ReservesCr
00001121-4-6-11
Current Liabilities
Current LiabilitiesCr
02101011117791323
Non Current Liabilities
Non Current LiabilitiesCr
012556556812
Total Liabilities
Total LiabilitiesCr
58172021231818151928
Current Assets
Current AssetsCr
2499910786917
Non Current Assets
Non Current AssetsCr
3481112121110101011
Total Assets
Total AssetsCr
58172021231818151928
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
44444444444
Reserves
ReservesCr
00001121-4-6-11
Current Liabilities
Current LiabilitiesCr
02101011117791323
Non Current Liabilities
Non Current LiabilitiesCr
012556556812
Total Liabilities
Total LiabilitiesCr
58172021231818151928
Current Assets
Current AssetsCr
2499910786917
Non Current Assets
Non Current AssetsCr
3481112121110101011
Total Assets
Total AssetsCr
58172021231818151928

Cash Flow

Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
0-14134100-1-2
Investing Cash Flow
Investing Cash FlowCr
00-4-3-2-3-2-1-2-1-1
Financing Cash Flow
Financing Cash FlowCr
011300-10114
Net Cash Flow
Net Cash FlowCr
001101-2-1001
Free Cash Flow
Free Cash FlowCr
0-10-200-1-1-2-1-3
CFO To PAT
CFO To PAT%
129.56,395.07,15,048.51,175.1659.0467.3529.6-320.13.431.356.6
CFO To EBITDA
CFO To EBITDA%
10.1918.1358.983.1159.8103.229.314.85.8-257.964.7
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
0-14134100-1-2
Investing Cash Flow
Investing Cash FlowCr
00-4-3-2-3-2-1-2-1-1
Financing Cash Flow
Financing Cash FlowCr
011300-10114
Net Cash Flow
Net Cash FlowCr
001101-2-1001
Free Cash Flow
Free Cash FlowCr
0-10-200-1-1-2-1-3
CFO To PAT
CFO To PAT%
129.56,395.07,15,048.51,175.1659.0467.3529.6-320.13.431.356.6
CFO To EBITDA
CFO To EBITDA%
10.1918.1358.983.1159.8103.229.314.85.8-257.964.7

Ratios

Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
5713151111161194
Price To Earnings
Price To Earnings
21.0127.7
Price To Sales
Price To Sales
0.60.50.80.71.00.60.95.1
Price To Book
Price To Book
1.31.82.73.02.3118.7-9.4-2.120.4
EV To EBITDA
EV To EBITDA
-109.47.54.77.36.8-4.993.5-6.1-41.5
Profitability Ratios
Profitability Ratios
GPM
GPM%
33.134.329.533.642.642.77.215.90.40.4
OPM
OPM%
9.19.38.413.014.014.6-30.50.9-30.1-13.6
NPM
NPM%
0.00.72.02.90.8-0.7-52.0-7.4-34.3-6.5
ROCE
ROCE%
0.20.10.51.38.513.96.64.0-83.7-29.7-77.9-77.9
ROE
ROE%
-0.1-0.20.01.78.513.02.4-1.8-5,459.0105.367.767.7
ROA
ROA%
-0.1-0.10.00.42.03.30.8-0.6-37.5-11.2-14.8-14.8
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
5713151111161194
Price To Earnings
Price To Earnings
21.0127.7
Price To Sales
Price To Sales
0.60.50.80.71.00.60.95.1
Price To Book
Price To Book
1.31.82.73.02.3118.7-9.4-2.120.4
EV To EBITDA
EV To EBITDA
-109.47.54.77.36.8-4.993.5-6.1-41.5
Profitability Ratios
Profitability Ratios
GPM
GPM%
33.134.329.533.642.642.77.215.90.40.4
OPM
OPM%
9.19.38.413.014.014.6-30.50.9-30.1-13.6
NPM
NPM%
0.00.72.02.90.8-0.7-52.0-7.4-34.3-6.5
ROCE
ROCE%
0.20.10.51.38.513.96.64.0-83.7-29.7-77.9-77.9
ROE
ROE%
-0.1-0.20.01.78.513.02.4-1.8-5,459.0105.367.767.7
ROA
ROA%
-0.1-0.10.00.42.03.30.8-0.6-37.5-11.2-14.8-14.8
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios

Documents — Parmax Pharma Ltd

  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/p04p6ovfd3m01ay65p2mv22e.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/kzi1vsxax33nd9zjks8y9vbh.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/t8kaqdrp19zc7fao8ull7z40.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/rjblng7h914tr1wfrlk0jv1l.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/lwu212956715nojxoulaefkz.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/6q3ndy16owh7qk4vm9n10844.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/5novajgyxq4fcgtwm1qrzxxm.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/pwgc9zm00jui7ouqyxx30ln2.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/phhdcywqad91jkhan3atsylf.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/vilovdnw51rypjp1cqgyi3iu.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/mh8k99kjbtm42j6s0jlesbup.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/8jrwvme86o0iy2s7scidukk3.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/11u0ezck1ob6ycsrijloygee.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/milgrz0u0k7k6ghbbbf9jqh6.pdf
  • FY2020 Annual Report (PDF): https://www.stockscans.in/document/5vz50qo15bs71dfqjdwlo8e4.pdf

Simplify stock analysis with powerful tools and clear insights for confident, data-driven decisions.

support@stockscans.in
© StockScans by SOIC Technologies Pvt Ltd
349 A, Lodhi Road, Punjabi Bazar, New DelhiData provided by CMOTS Internet Technologies